PRAME Protein (AA 321-420) (His-IF2DI Tag)
-
- Target Alle PRAME Proteine anzeigen
- PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))
- Protein-Typ
- Recombinant
- Proteineigenschaft
- AA 321-420
- Spezies
- Human
-
Quelle
- Escherichia coli (E. coli)
- Aufreinigungstag / Konjugat
- Dieses PRAME Protein ist gelabelt mit His-IF2DI Tag.
- Applikation
- Western Blotting (WB), ELISA
- Reinheit
- Greater than 95 % as determined by SDS-PAGE
- Sterilität
- 0.2 μm filtered
- Top Product
- Discover our top product PRAME Protein
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Centrifuge the vial at 10,000 rpm for 1 minute, reconstitute at 200 μg/mL in sterile distilled water by gentle pipetting 2-3 times, don't vortex
- Buffer
- Lyophilized from a 0.2 μm filtered solution in 10 mM Hepes, 500 mM NaCl with 5 % trehalose, pH 7.4
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- -20°C for 12 months as lyophilized, 2-8°C for 1 month under sterile conditions after reconstitution
- Haltbarkeit
- 12 months
-
- Target
- PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))
- Andere Bezeichnung
- PRAME (PRAME Produkte)
- Synonyme
- PRAME Protein, CT130 Protein, MAPE Protein, OIP-4 Protein, OIP4 Protein, 4930534P07Rik Protein, preferentially expressed antigen in melanoma Protein, PRAME Protein, Prame Protein
- Hintergrund
- 4930534P07Rik, Cancer/testis antigen 130, CT130, MAPE, Melanoma antigen preferentially expressed in tumors, OIP 4, OIP-4, OIP4, OPA interacting protein 4, Opa interacting protein OIP4, OPA-interacting protein 4, PRAME, PRAME_HUMAN
- Molekulargewicht
- 31.3 kDa
- UniProt
- P78395
- Pathways
- Retinoic Acid Receptor Signaling Pathway, Nuclear Hormone Receptor Binding
-